Theranexus
Clinical-stage biopharmaceutical company developing treatments for rare neurological disorders.
ALTHX | PA
Overview
Corporate Details
- ISIN(s):
- FR0013286259
- LEI:
- 969500BFCV6IC7MFQP20
- Country:
- France
- Address:
- 60 AVENUE ROCKEFELLER, 69008 LYON
- Website:
- https://www.theranexus.com/en/
- Sector:
- Manufacturing
Description
THX Pharma (formerly Theranexus) is an innovative, clinical-stage biopharmaceutical company that emerged from the French Alternative Energies and Atomic Energy Commission (CEA). The company specializes in developing treatments for rare neurological disorders. It leverages a unique platform for the identification and characterization of advanced therapy drug candidates. Its lead program is a drug candidate in clinical development for Batten disease, a rare neurodegenerative disorder.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-01-05 18:00 |
New advance to the Theranexus and BBDF Batten-1 program for juvenile Batten dis…
|
English | 444.6 KB | ||
| 2022-12-21 18:00 |
THERANEXUS PUBLIE SON AGENDA FINANCIER POUR L'EXERCICE 2023
|
French | 190.9 KB | ||
| 2022-12-21 18:00 |
THERANEXUS ANNOUNCES ITS FINANCIAL CALENDAR FOR 2023
|
English | 182.7 KB | ||
| 2022-12-20 18:00 |
THERANEXUS ANNONCE SA PARTICIPATION A LA ' 41ST ANNUAL J.P. MORGAN HEALTHCARE C…
|
French | 205.2 KB | ||
| 2022-12-20 18:00 |
THERANEXUS ANNOUNCES PARTICIPATION IN THE 41ST ANNUAL J.P. MORGAN HEALTHCARE CO…
|
English | 205.0 KB | ||
| 2022-11-02 18:00 |
THERANEXUS AND BBDF PRESENT PROGRESS ON THE BATTEN-1 PROGRAM AT THE TRANSLATION…
|
English | 404.8 KB | ||
| 2022-11-02 18:00 |
THERANEXUS ET LA FONDATION BBDF PRÉSENTENT LES AVANCÉES DU PROGRAMME BATTEN-1 L…
|
French | 420.7 KB | ||
| 2022-10-20 18:00 |
THERANEXUS ET INSERM TRANSFERT SIGNENT UNE ALLIANCE STRATÉGIQUE POUR IDENTIFIER…
|
French | 272.6 KB | ||
| 2022-10-20 18:00 |
THERANEXUS AND INSERM TRANSFERT SIGN A STRATEGIC ALLIANCE TO IDENTIFY ADVANCED …
|
English | 396.7 KB | ||
| 2022-10-19 18:05 |
Theranexus publie sa position de trésorerie au 30 septembre 2022
|
French | 214.1 KB | ||
| 2022-10-19 18:00 |
Theranexus publishes its cash position as of 30 September 2022
|
English | 184.0 KB | ||
| 2022-09-27 17:45 |
THERANEXUS ANNOUNCES ITS FINANCIAL RESULTS FOR THE FIRST HALF OF 2022
|
English | 235.1 KB | ||
| 2022-09-27 17:45 |
THERANEXUS ANNONCE SES RÉSULTATS FINANCIERS DU PREMIER SEMESTRE 2022
|
French | 241.7 KB | ||
| 2022-09-08 18:00 |
Theranexus et la fondation BBDF finalisent le recrutement de l'étude de phase I…
|
French | 413.7 KB | ||
| 2022-09-08 18:00 |
Theranexus and BBDF finalize recruitment for phase I/II trial to evaluate Batte…
|
English | 411.3 KB |
Automate Your Workflow. Get a real-time feed of all Theranexus filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Theranexus
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Theranexus via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
